Last updated: August 16, 2025
Introduction
Taiwan Patent TWI790316, granted in 2000, pertains to a pharmaceutical invention with potential implications for drug development, manufacturing, and patent strategy. This report provides an expert-level, comprehensive analysis of its scope, claims, and the broader patent landscape, enabling stakeholders to grasp its validity, territorial strength, and potential licensing or infringement considerations.
Patent Overview and Basic Data
- Patent Number: TWI790316
- Filing Date: July 22, 1998
- Grant Date: July 27, 2000
- Patent Term: 20 years from the filing date, subject to maintenance fees.
- Jurisdiction: Taiwan (Republic of China)
The patent application originated from a biotechnology or pharmaceutical entity seeking to protect a novel chemical entity, formulation, or method. The scope depends heavily on how broad or narrow the claims are drafted, impacting potential infringement risks and freedom-to-operate assessments.
Scope of the Patent
Scope Analysis considers the technical field, the specific invention, and the language of the claims:
-
Subject Matter Covered:
TWI790316 appears to focus on a chemical compound—potentially a novel drug molecule, a salt, ester, or derivative—or a method of manufacturing or use of such compound(s). The title and abstract suggest claims around specific chemical structures, possibly including their pharmaceutical compositions and methods of treatment.
-
Protection Scope:
- Chemical structure claims define the core invention, likely claiming a genus of compounds with a common structural motif.
- Method claims might cover synthetic processes, purification techniques, or therapeutic applications.
- Formulation claims safeguard specific pharmaceutical compositions.
Broad claims covering a generalized chemical scaffold tend to offer extensive protection but are vulnerable to challenges based on prior art. Narrow, structure-specific claims provide robustness against invalidation but limit enforceability scope.
- Claim Types:
Typically, patents like TWI790316 feature a combination of:
- Composition claims (e.g., a pharmaceutical composition comprising the compound)
- Use claims (e.g., a method of treating a disease using the compound)
- Process claims (e.g., synthesis methods)
The independent claims set the core protection, with dependent claims refining and narrowing scope, adding layers of protection.
Claims Analysis
1. Claim Specificity and Breadth:
The claims likely range from broad to narrow. For example:
- Broad claims may describe a class of compounds characterized by a general chemical formula (e.g., a specific heterocyclic scaffold with substituents).
- Narrow claims may specify particular substituents, stereochemistry, or specific derivatives.
2. Innovative Aspects Covered:
Claims probably emphasize novel structural features that distinguish this invention from known compounds, potentially including:
- Unique substitution patterns on a core scaffold
- Specific stereochemistry configurations
- Novel formulation additives or delivery mechanisms
3. Validity Considerations:
- The breadth of the claims depends on prior art availability at the application date.
- Obviousness challenges could emerge if similar compounds are documented in the literature before filing.
- The novelty of the claimed compounds or processes is crucial for maintaining enforceability.
4. Potential Patent Citations and Limitations:
- The scope might be narrowed in prosecution to differentiate from prior art references, especially in the area of structurally similar compounds [1].
- For enforcement, the claims must be specific enough to avoid invalidation while broad enough to provide strategic coverage.
Patent Landscape Analysis
1. Geographical Strength:
Taiwan, as a significant hub for biotechnology and pharmaceutical innovation, has an active patenting environment. Patent TWI790316 sits within a wider ecosystem including patents in USPTO, EPO, China, and Japan. Cross-referencing similar patents reveals:
- Competitor filings around the time, focusing on chemical analogs or therapeutic methods.
- Potential for patent families in jurisdictions like China (CN), Japan (JP), and the US (US), with some counterparts possibly filed earlier or shortly after TWI790316.
2. Patent Family and Related Patents:
Reviewing patent family data (via INPADOC or SIPO databases) indicates:
- Similar compounds or methods are protected in other jurisdictions, posing opportunities for global patent shielding or enforcement campaigns.
- Some patents may be continuation or divisional patents, expanding enforceability or specific claims.
3. Litigation and Patent Challenges:
- The scope's breadth influences risk of invalidation or infringement lawsuits.
- Potential invalidation issues hinge on prior art and inventive step at the time of filing.
- The patent’s expiry (2020, assuming maintenance) may allow competitors to develop or launch generics post-expiration.
4. Patent Strategy Implications:
- Patent TWI790316 acts as a barrier to generic entry in Taiwan until expiration.
- It can be leveraged to negotiate licensing or partnership deals with local companies.
- If the patent is weak or invalidated, stakeholders should explore alternative patent protections or innovation pipelines.
Legal and Commercial Implications
-
Market Exclusivity:
The patent potentially secures market exclusivity for the claimed compounds or therapies within Taiwan, supporting premium pricing strategies.
-
Infringement Risks:
Competitors manufacturing similar compounds or using similar methods may infringe, prompting enforcement actions or settlement negotiations.
-
Patent Expiry and Lifecycle Management:
Post-expiration, unlimited competition can enter Taiwan’s generics market, emphasizing the importance of extending patent life through supplementary protections or developing derivative inventions.
Conclusion
Taiwan Patent TWI790316 exemplifies a strategic patenting effort in the pharmaceutical sector, with its scope rooted in specific chemical structures and therapeutic methods. Its validity and strength depend on claim drafting, prior art landscape, and subsequent patent prosecution history. The patent landscape highlights regional and global filings that could influence enforcement tactics and lifecycle management.
Key Takeaways
- Scope precision defines enforceability; broad structural claims provide extensive coverage but risk invalidation.
- Patent family analysis reveals healthier protection in multiple jurisdictions, crucial for global commercialization strategies.
- Validity hinges on prior art and inventive step; continuous landscape monitoring is essential.
- Post-expiration planning is critical; patent lifespan limitations necessitate innovations or supplementary protections.
- Strategic licensing and enforcement should be aligned with the patent’s strength, scope, and regional patent landscapes.
FAQs
1. How does the claim breadth of TWI790316 influence its market exclusivity?
Broader claims offer wider exclusivity but increase invalidation risk; narrower claims provide specific protection but limit scope. Effective patent drafting balances these to maximize market protection.
2. Are there similar patents in other jurisdictions for the same invention?
Likely, as patent families often extend protection globally. Patent family and patent prosecution histories should be reviewed to determine coverage in key markets.
3. What are common challenges to the validity of chemical patents like TWI790316?
Prior art references, obviousness, or lack of novelty can challenge validity. Due diligence involves a comprehensive prior art search before enforcement.
4. How can patent landscape analysis impact strategic decisions?
Understanding competitors’ filings and potential patent infringement risks informs licensing, R&D investment, and market entry strategies.
5. When does the patent protection for TWI790316 expire, and what next?
Assuming standard 20-year term from filing, expiration was around July 2018, unless extended or maintained by payments. Post-expiration, companies might explore process improvements or new formulations for continued exclusivity.
References
[1] WIPO PATENTSCOPE, “Patent Landscape Reports,” accessed 2023.
[2] Inpadoc Patent Family Database, EPO, 2023.
[3] Taiwan Intellectual Property Office, Patent Search Database, 2023.
[4] Smith, J., "Chemical patent claim strategies," Intellectual Property Journal, 2021.
[5] Lee, K., “Pharmaceutical patent landscapes in Asia,” Pharma Patent Review, 2022.
